Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/23/2026 | $55.00 | Neutral → Buy | Citigroup |
| 1/29/2026 | $55.00 | Outperform | BMO Capital Markets |
| 9/19/2025 | $51.00 | Buy | UBS |
| 7/18/2025 | $41.00 | Outperform | Robert W. Baird |
| 6/30/2025 | $42.00 | Sector Outperform | Scotiabank |
| 4/28/2025 | $37.00 | Buy | Jefferies |
| 3/14/2024 | $18.00 | Overweight | Barclays |
| 3/4/2024 | $15.00 | Buy | BofA Securities |
American Healthcare REIT, Inc. (NYSE:AHR) announced today that its board of directors has declared a quarterly distribution of $0.25 per share for the quarter ending June 30, 2026. The distribution will be payable in cash on or about July 17, 2026, to all holders of record of its common stock as of the close of business on June 30, 2026. About American Healthcare REIT, Inc. American Healthcare REIT, Inc. (NYSE:AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, and in the U
American Healthcare REIT, Inc. (NYSE:AHR) announced today that Chairman and Interim Chief Executive Officer, Jeff Hanson, Chief Financial Officer, Brian Peay, Chief Operating Officer, Gabe Willhite, and Vice President of Investor Relations and Finance, Alan Peterson, will deliver a company presentation at Nareit's REITweek: 2026 Investor Conference on Tuesday, June 2, 2026, from 11:00 a.m. to 11:30 a.m. Eastern Time. A live webcast of the presentation will be available at the following link. A replay will be available at the same link following the completion of the conference on June 2, 2026 for up to 60 days. About American Healthcare REIT, Inc. American Healthcare REIT, Inc. (NYSE:AH
American Healthcare REIT, Inc. (NYSE:AHR, the "Company")) announced today the pricing of an underwritten public offering of 14,000,000 shares of its common stock, all of which are being offered in connection with the forward sale agreement described below. The aggregate gross proceeds to the Company from the offering, before deducting estimated offering expenses, are expected to be approximately $705.6 million. The offering is expected to close May 22, 2026, subject to customary closing conditions. BofA Securities is acting as the underwriter for the offering. In connection with the offering, the Company entered into a forward sale agreement with BofA Securities (or an affiliate thereof
8-K - American Healthcare REIT, Inc. (0001632970) (Filer)
8-K - American Healthcare REIT, Inc. (0001632970) (Filer)
8-K - American Healthcare REIT, Inc. (0001632970) (Filer)
4 - American Healthcare REIT, Inc. (0001632970) (Issuer)
4 - American Healthcare REIT, Inc. (0001632970) (Issuer)
4 - American Healthcare REIT, Inc. (0001632970) (Issuer)
4 - American Healthcare REIT, Inc. (0001632970) (Issuer)
Citigroup upgraded American Healthcare REIT from Neutral to Buy and set a new price target of $55.00
BMO Capital Markets initiated coverage of American Healthcare REIT with a rating of Outperform and set a new price target of $55.00
UBS initiated coverage of American Healthcare REIT with a rating of Buy and set a new price target of $51.00
SC 13G - American Healthcare REIT, Inc. (0001632970) (Subject)
SC 13G/A - American Healthcare REIT, Inc. (0001632970) (Subject)
SC 13G/A - American Healthcare REIT, Inc. (0001632970) (Subject)
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc
American Healthcare REIT, Inc. (NYSE:AHR) announced today that its board of directors has declared a quarterly distribution of $0.25 per share for the quarter ending June 30, 2026. The distribution will be payable in cash on or about July 17, 2026, to all holders of record of its common stock as of the close of business on June 30, 2026. About American Healthcare REIT, Inc. American Healthcare REIT, Inc. (NYSE:AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, and in the U
IRVINE, Calif., May 7, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE:AHR) (the "Company," "we," "our," or "AHR") is announcing today its first quarter 2026 results and increasing full year 2026 guidance. Key Highlights:Reported GAAP net income attributable to controlling interest of $23.7 million, or $0.13 per diluted share, for the three months ended March 31, 2026.Reported Normalized Funds From Operations attributable to common stockholders ("NFFO") of $0.50 per diluted share for the three months ended March 31, 2026, representing over 30% growth compared to the sa
NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Land & Buildings Investment Management, LLC Welltower Shares Trade at 144% Premium to NAV and 33x FFO: Investors Switching to Ventas or American Healthcare REIT Receive 50% More Asset Value Per Dollar Estimates Shares Could See ~35%-60% Downside From Current Levels to Match Peer Valuations – Discloses Short Position in Welltower Today, Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings," "L&B," "us" or "we"), issued a white paper on Welltower, Inc. (NYSE:WELL) ("Welltower" or the "Company"), titled Compensation Plan Hubris: Why Welltower's Ten-Year Executive Program Is Likely to